Oversold due for a bouncePDSB long here, long term position. Oversold in multiple timeframes for no actual reason.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.17 USD
−42.94 M USD
0.00 USD
36.00 M
About PDS Biotechnology Corporation
Sector
CEO
Frank K. Bedu-Addo
Headquarters
Princeton
Website
Founded
2005
FIGI
BBG004NCDK82
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
$PDSB Twittering MisinformationStocks are reflections of human interest, and as such they are not paragons of truth. A single strand of misinformation could have catastrophic implications for a stock, which is what happened to PDS Biotechnology Corporation (NASDAQ: PDSB). After an allegation concerning the validity of its trial r
Watchlist 2023-05-30 $MRVL $ON $PDD $PDSB $LXRX $GPSAMEX:SPY is trading sharply higher to start the week post long weekend as a provisional agreement was reached among lawmakers to increase the national debt limit, averting a potential default. This news coincided with an early rally in the market, led primarily by shares of Nvidia, a leading chipma
Short into resistance Shorted into $9.00 level. Covered short next day into weakness as it approached $8.00 level at 8.25
$pdsb - holding on for dear life or perfect entry point to long?Looks like PDSB is coiling up and either going to break support or rocket to the moon.
PDSB SELL ++++PDSB overbought on ER. Generally not a fan of biotech and pharma stocks. This spike is overdone the ANALysts claim this is a $14 stock (where were they when it was $2?) blah blah blah. We should correct under $7 in coming weeks
PDSB ahead of earnings PDSB ahead of earnings could be crazy bullish cross on rsi and macd, i know im not the only one seeing this, how are more people not posting ideas in relation? am i missing something
Khan's Chart-Requests 10 - PDSBFound a nice support on Standard Deviation 1, but MACD crossover + bearish divergence could lead into a shortterm downtrend
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where PDSB is featured.
Frequently Asked Questions
The current price of PDSB is 2.20 USD — it has decreased by −3.34% in the past 24 hours. Watch PDS Biotechnology Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PDS Biotechnology Corporation stocks are traded under the ticker PDSB.
PDSB stock has fallen by −32.72% compared to the previous week, the month change is a −37.11% fall, over the last year PDS Biotechnology Corporation has showed a −65.02% decrease.
We've gathered analysts' opinions on PDS Biotechnology Corporation future price: according to them, PDSB price has a max estimate of 21.00 USD and a min estimate of 4.50 USD. Watch PDSB chart and read a more detailed PDS Biotechnology Corporation stock forecast: see what analysts think of PDS Biotechnology Corporation and suggest that you do with its stocks.
PDSB reached its all-time high on Oct 14, 2015 with the price of 517.40 USD, and its all-time low was 0.62 USD and was reached on Apr 2, 2020. View more price dynamics on PDSB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PDSB stock is 9.18% volatile and has beta coefficient of 2.78. Track PDS Biotechnology Corporation stock price on the chart and check out the list of the most volatile stocks — is PDS Biotechnology Corporation there?
Today PDS Biotechnology Corporation has the market capitalization of 75.75 M, it has decreased by −10.00% over the last week.
Yes, you can track PDS Biotechnology Corporation financials in yearly and quarterly reports right on TradingView.
PDS Biotechnology Corporation is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
PDSB earnings for the last quarter are −0.29 USD per share, whereas the estimation was −0.30 USD resulting in a 2.25% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about PDS Biotechnology Corporation earnings.
PDS Biotechnology Corporation revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
PDSB net income for the last quarter is −10.73 M USD, while the quarter before that showed −8.33 M USD of net income which accounts for −28.80% change. Track more PDS Biotechnology Corporation financial stats to get the full picture.
No, PDSB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 25.00 employees. See our rating of the largest employees — is PDS Biotechnology Corporation on this list?
Like other stocks, PDSB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PDS Biotechnology Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PDS Biotechnology Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PDS Biotechnology Corporation stock shows the sell signal. See more of PDS Biotechnology Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.